Therefore, cognitive decline after stroke may not be accelerated by the presence of ApoE ε4, which is consistent with the Chicago Health and Aging Project (CHAP) study, suggesting that cognitive decline before and after stroke was not significantly different among those with the ApoE ε4 allele [25]. The gene discussed is APOE; the disease is Stroke.